Cardiac protection of Bauhinia championii against reperfusion injury

This study aims to investigate the protective effects of the Bauhinia championii (BC) against ischemia/reperfusion (I/R)‐induced injury in an isolated heart model. Langendorff‐perfused C57BL/6JNarl mice hearts were performed with 30 minutes ischemia and 60 minutes reperfusion by left anterior descen...

Full description

Saved in:
Bibliographic Details
Published inEnvironmental toxicology Vol. 35; no. 7; pp. 774 - 782
Main Authors Chen, Yun‐Fang, Chen, Wei‐Yu, Chung, Ching‐Hu, Kuo, Chao‐Lin, Lee, An‐Sheng
Format Journal Article
LanguageEnglish
Published Hoboken, USA John Wiley & Sons, Inc 01.07.2020
Wiley Subscription Services, Inc
Subjects
Online AccessGet full text
ISSN1520-4081
1522-7278
1522-7278
DOI10.1002/tox.22912

Cover

More Information
Summary:This study aims to investigate the protective effects of the Bauhinia championii (BC) against ischemia/reperfusion (I/R)‐induced injury in an isolated heart model. Langendorff‐perfused C57BL/6JNarl mice hearts were performed with 30 minutes ischemia and 60 minutes reperfusion by left anterior descending artery ligation. Before reperfusion, boiling water extracts of BC (10 mg/L) was pretreated for 15 minutes. During reperfusion, BC significantly decreased the occurrence of ventricular arrhythmias by lead II electrocardiogram (ECG). Electrophysiological effect of BC was further determined in isolated ventricular myocytes by whole‐cell patch clamp technique. The underlying mechanism may result from its Na+ channel blocking activity characterized with reduced rise slope of action potential and Na+ current density. Moreover, BC dramatically reduced I/R‐caused infarct size, which was accessed by 2,3,5‐triphenyltetrazolium chloride (TTC) assay. Since BC decreased I/R‐induced myoglobin release and oxidation of Ca2+‐calmodulin‐dependent protein kinase, inhibition of myocardial necroptosis may account for the protective effects of BC on myocytes lose. This study indicated that BC may prevent I/R induced ventricular arrhythmias and myocyte death by blocking Na+ channels and decreasing necroptosis, respectively. Since most of the available antiarrhythmic remedies have unwanted adverse actions, BC could be a novel candidate for the treatment of myocardial infarction and ventricular arrhythmia.
Bibliography:Funding information
Mackay Medical College, Grant/Award Numbers: 1041B08, 1051B11, 1061B23, 1071B01; Ministry of Science and Technology, Taiwan, Grant/Award Numbers: MOST 107‐2320‐B‐715‐002‐MY3, MOST‐104‐2320‐B‐715‐009‐MY3
ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 14
content type line 23
ISSN:1520-4081
1522-7278
1522-7278
DOI:10.1002/tox.22912